Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Scope
1.2.2 Markets Covered
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Revenue Mapping-Based Market Estimation
2.5 Data Triangulation
2.5.1 Assumptions for the Study
2.5.2 Limitations
3 Executive Summary
4 Premium Insights
4.1 Stable Isotope-Labeled Compounds: Market Overview
4.2 North America: Stable Isotope-Labeled Compounds, By Application (2018)
4.3 Geographical Snapshot of the Stable Isotope-Labeled Compounds Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in Research Activities in the Pharmaceutical and Biotechnology Sector
5.2.1.2 Growing Proteomics Research
5.2.1.3 Rising Prevalence of Cancer
5.2.2 Restraints
5.2.2.1 High Cost of Stable Isotope-Labeled Compounds
5.2.3 Opportunities
5.2.3.1 Rising Investments in Pharmaceutical R&D in Emerging Markets
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
6 Stable Isotope-Labeled Compounds Market, By Type
6.1 Introduction
6.2 Hydrogen-2
6.2.1 Growing Applications of H-2 in Pharmaceutical Research Will Drive Demand for Labeled Compounds
6.3 Carbon-13
6.3.1 Rising Number of Metabolomics Studies and Applications in Disease Diagnosis are Driving Market Growth
6.4 Oxygen-18
6.4.1 Increasing Research on Cancer is Expected to Drive Demand for O-18 Labeled Isotopes
6.5 Nitrogen-15
6.5.1 Expanding Applications of N-15 in Agricultural Investigation and Rising Research are Likely to Drive Market Demand
6.6 Other Stable Isotopes
7 Stable Isotope-Labeled Compounds Market, By Application
7.1 Introduction
7.2 Research
7.2.1 Increasing Research Activities Involving Stable Isotopes to Support Market Growth
7.2.2 Biomedical Research
7.2.3 Pharmaceutical Research
7.2.4 Environmental & Ecological Research
7.2.5 Agricultural Research
7.3 Clinical Diagnostics
7.3.1 Increasing Adoption of Pet Scans and Gamma Imaging for Disease Staging to Support Market Growth
7.4 Industrial Applications
7.4.1 Rising Applications of Stable Isotopes in the Nuclear Industry and the Growing Number of Nuclear Reactors to Support Market Growth
7.5 Other Applications
8 Stable Isotope-Labeled Compounds Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increase in R&D Activities is Expected to Drive Demand for Stable Isotope-Labeled Compounds
8.3 Academic & Research Institutes
8.3.1 Rising Prevalence of Diseases and Growing Research Into Therapies have Driven the Growth of This End-User Segment
8.4 Hospitals & Diagnostic Centers
8.4.1 Adoption of Stable Isotopes has Increased Owing to the Rising Prevalence of Target Diseases
8.5 Other End Users
9 Stable Isotope-Labeled Compounds Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Availability of Funding Will Drive the Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany is the Fastest-Growing Market in Europe
9.3.2 UK
9.3.2.1 Favorable Scenario for Environmental Research and Increasing Prevalence of Cancer are Key Growth Drivers in the UK
9.3.3 France
9.3.3.1 France has A Large and Well-Developed Biotech Industry
9.3.4 Italy
9.3.4.1 Strong Government Support for Research has Stimulated Market Growth in Italy
9.3.5 Spain
9.3.5.1 Rising Research Activity and Expenditure Shows Significant Market Growth Potential in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Dominates the Market in the APAC
9.4.2 Japan
9.4.2.1 Growing Support and Funding have Raised Research Intensity in Japan
9.4.3 India
9.4.3.1 Government Initiatives have Strengthened the Life Science Industry in India
9.4.4 Australia
9.4.4.1 Growing Funding for Research and Collaborations have Supported Market Growth in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (Overall Market) (2018)
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Cambridge Isotope Laboratories
11.2 Merck KGaA
11.3 URENCO Limited
11.4 IsoSciences
11.5 Medical Isotopes
11.6 Omicron Biochemicals
11.7 Trace Sciences International
11.8 Alsachim
11.9 Taiyo Nippon Sanso Corporation
11.10 Perkinelmer
11.11 Rotem Industries Israel
11.12 Boc Sciences
11.13 Cortecnet
11.14 Isoflex
11.15 Huayi Isotopes Co.
11.16 Mesbah Energy Co.
11.17 Shanghai Research Institute of Chemical Industry
11.18 13c Molecular
11.19 C/D/N Isotope
11.20 Shoko Co.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables
Table 1 Company Drug Pipelines, 2019
Table 2 Top Investors in R&D, 2016 vs 2017
Table 3 Global Cancer Incidence, 2018 vs 2025
Table 4 Government Funding Programs for Pharmaceutical R&D in Emerging Nations
Table 5 Stable Isotope-Labeled Compounds Market, By Type, 2017–2024 (USD Million)
Table 6 H-2 Labeled Compounds Market, By Region, 2017–2022 (USD Million)
Table 7 North America: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 8 Europe: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 9 APAC: H-2 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 10 C-13 Labeled Compounds Market, By Region, 2017–2024 (USD Million)
Table 11 North America: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 13 APAC: C-13 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 14 O-18 Labeled Compounds Market, By Region, 2017–2024 (USD Million)
Table 15 North America: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 16 Europe: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 17 APAC: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 18 N-15 Labeled Compounds Market, By Region, 2017–2022 (USD Million)
Table 19 North America: N-15 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 20 Europe: N-15 Labeled Compounds Market, By Country, 2017–2024 (USD Million)
Table 21 APAC: O-18 Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 22 Other Market, By Region, 2017–2022 (USD Thousand)
Table 23 North America: Other Market, By Country, 2017–2024 (USD Thousand)
Table 24 Europe: Other Stable Isotope-Labeled Compounds Market, By Country, 2017–2024 (USD Thousand)
Table 25 APAC: Other Market, By Country, 2017–2024 (USD Thousand)
Table 26 Market, By Application, 2017–2024 (USD Million)
Table 27 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 30 APAC: Stable Isotope-Labeled Compounds Market for Research Applications, By Country, 2017–2024 (USD Million)
Table 31 Market for Clinical Diagnostic Applications, By Region, 2017–2024 (USD Million)
Table 32 North America: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Million)
Table 33 Europe: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Million)
Table 34 APAC: Market for Clinical Diagnostic Applications, By Country, 2017–2024 (USD Thousand)
Table 35 Stable Isotope-Labeled Compounds Market for Industrial Applications, By Region, 2017–2024 (USD Million)
Table 36 North America: Market for Industrial Applications, By Country, 2017–2024 (USD Million)
Table 37 Europe: Market for Industrial Applications, By Country, 2017–2024 (USD Thousand)
Table 38 APAC: Market for Industrial Applications, By Country, 2017–2024 (USD Thousand)
Table 39 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 40 North America: Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 41 Europe: Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 42 APAC: Stable Isotope-Labeled Compounds Market for Other Applications, By Country, 2017–2024 (USD Thousand)
Table 43 Market, By End User, 2017–2024 (USD Million)
Table 44 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 45 North America: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 46 Europe: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 47 APAC: Market for Pharmaceutical & Biotechnology Companies, By Country, 2017–2024 (USD Thousand)
Table 48 Market for Academic & Research Institutes, By Region, 2017–2024 (USD Million)
Table 49 North America: Stable Isotope-Labeled Compounds Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 50 Europe: Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 51 APAC: Market for Academic & Research Institutes, By Country, 2017–2024 (USD Thousand)
Table 52 Market for Hospitals & Diagnostic Centers, By Region, 2015–2022 (USD Million)
Table 53 North America: Stable Isotope-Labeled Compounds Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 54 Europe: Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 55 APAC: Market for Hospitals & Diagnostic Centers, By Country, 2017–2024 (USD Thousand)
Table 56 Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 57 North America: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 58 Europe: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 59 APAC: Market for Other End Users, By Country, 2017–2024 (USD Thousand)
Table 60 Market, By Region, 2017–2024 (USD Million)
Table 61 North America: Market, By Country, 2017–2024 (USD Million)
Table 62 North America: Market, By Type, 2017–2024 (USD Million)
Table 63 North America: Market, By Application, 2017–2024 (USD Million)
Table 64 North America: Market, By End User, 2017–2024 (USD Million)
Table 65 US: Market, By Type, 2017–2024 (USD Million)
Table 66 US: Market, By Application, 2017–2024 (USD Million)
Table 67 US: Market, By End User, 2017–2024 (USD Million)
Table 68 Canada: Stable Isotope-Labeled Compounds Market, By Type, 2017–2024 (USD Thousand)
Table 69 Canada: Market, By Application, 2017–2024 (USD Thousand)
Table 70 Canada: Market, By End User, 2017–2024 (USD Thousand)
Table 71 Europe: Market, By Country, 2017–2024 (USD Million)
Table 72 Europe: Market, By Type, 2017–2024 (USD Million)
Table 73 Europe: Market, By Application, 2017–2024 (USD Million)
Table 74 Europe: Market, By End User, 2017–2024 (USD Million)
Table 75 Germany: Market, By Type, 2017–2024 (USD Million)
Table 76 Germany: Stable Isotope-Labeled Compounds Market, By Application, 2017–2024 (USD Million)
Table 77 Germany: Market, By End User, 2017–2024 (USD Million)
Table 78 UK: Market, By Type, 2017–2024 (USD Million)
Table 79 UK: Market, By Application, 2017–2024 (USD Million)
Table 80 UK: Market, By End User, 2017–2024 (USD Million)
Table 81 France: Market, By Type, 2017–2024 (USD Thousand)
Table 82 France: Stable Isotope-Labeled Compounds Market, By Application, 2017–2024 (USD Thousand)
Table 83 France: Market, By End User, 2015–2022 (USD Thousand)
Table 84 Italy: Market, By Type, 2017–2024 (USD Thousand)
Table 85 Italy: Market, By Application, 2017–2024 (USD Thousand)
Table 86 Italy: Market, By End User, 2017–2024 (USD Thousand)
Table 87 Spain: Market, By Type, 2017–2024 (USD Thousand)
Table 88 Spain: Market, By Application, 2017–2024 (USD Thousand)
Table 89 Spain: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 90 Pharmaceutical R&D Expenditure in RoE Countries (2016)
Table 91 RoE: Market, By Type, 2017–2024 (USD Thousand)
Table 92 RoE: Market, By Application, 2017–2024 (USD Thousand)
Table 93 RoE: Market, By End User, 2017–2024 (USD Thousand)
Table 94 Number of Nuclear Reactors in the Asia Pacific (August 2019)
Table 95 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 96 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 97 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 98 Asia Pacific: Stable Isotope-Labeled Compounds Market, By End User, 2015–2022 (USD Million)
Table 99 China: Market, By Type, 2017–2024 (USD Million)
Table 100 China: Market, By Application, 2017–2024 (USD Million)
Table 101 China: Market, By End User, 2017–2024 (USD Million)
Table 102 Japan: Market, By Type, 2017–2024 (USD Thousand)
Table 103 Japan: Market, By Application, 2015–2022 (USD Thousand)
Table 104 Japan: Market, By End User, 2017–2024 (USD Thousand)
Table 105 India: Market, By Type, 2017–2024 (USD Thousand)
Table 106 India: Market, By Application, 2017–2024 (USD Thousand)
Table 107 India: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 108 Australia: Market, By Type, 2017–2024 (USD Thousand)
Table 109 Australia: Market, By Application, 2017–2024 (USD Thousand)
Table 110 Australia: Market, By End User, 2017–2024 (USD Thousand)
Table 111 RoAPAC: Market, By Type, 2017–2024 (USD Thousand)
Table 112 RoAPAC: Market, By Application, 2017–2024 (USD Thousand)
Table 113 RoAPAC: Stable Isotope-Labeled Compounds Market, By End User, 2017–2024 (USD Thousand)
Table 114 RoW: Market, By Type, 2017–2024 (USD Thousand)
Table 115 RoW: Market, By Application, 2017–2024 (USD Thousand)
Table 116 RoW: Market, By End User, 2017–2024 (USD Thousand)
Table 117 Agreements (2016–2019)
Table 118 Product Launches (2016-2019)
List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Stable Isotope-Labeled Compounds Market
Figure 5 Market Data Triangulation Methodology
Figure 6 Market, By Type, 2019 vs 2024
Figure 7 Market, By Application, 2019 vs 2024
Figure 8 Market, By End User, 2019 vs 2024
Figure 9 Geographic Snapshot of the Stable Isotope-Labeled Compounds Market
Figure 10 Increase in Research in the Pharmaceutical and Biotechnology Sectors Will Drive the Growth of the Market
Figure 11 Research Segment Accounted for the Largest Share of the North American Market in 2018
Figure 12 North America to Register the Highest Growth During the Forecast Period
Figure 13 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 North America Dominates the Market in 2019
Figure 15 Asia Pacific: Market Snapshot
Figure 16 Market Ranking of Key Players, 2018
Figure 17 Competitive Leadership Mapping: Stable Isotope-Labeled Compounds Market
Figure 18 Merck KGaA: Company Snapshot
Figure 19 URENCO Limited: Company Snapshot (2018)
Figure 20 Taiyo Nippon Sanso Corporation: Company Snapshot (2018)
Figure 21 Perkinelmer: Company Snapshot (2018)
